DARA BioSciences (DARA) Misses Q1 EPS by 3c

DARA BioSciences (NASDAQ: DARA) reported Q1 EPS of ($0.16), $0.03 worse than the analyst estimate of ($0.13). Revenue for the quarter came in at $652.2 thousand versus the consensus estimate of $700 thousand.

Loss in Q114 was $0.37 per share.

For earnings history and earnings-related data on DARA BioSciences (DARA) click here.

You May Also Be Interested In

• North American Construction (NOA) Tops Q2 EPS by 9c; Offers Guidance
• Alto Neuroscience, Inc. (ANRO) Tops Q2 EPS by 10c
• CAE, Inc. (CAE) Tops Q1 EPS by 2c, Beats on Revenue; Offers FY27 EPS Guidance